Issue title: Selected papers from the 4th China–France Biotherapy and Regenerative Medicine International Symposium, Wuhan, June 2011
Article type: Research Article
Authors: Stoltz, J.-F.; ; ; | Decot, V.; ; | Huseltein, C.; | He, X. | Zhang, L. | Magdalou, J.; | Li, Y.P. | Menu, P.; | Li, N. | Wang, Y.Y.; ; | de Isla, N.; | Bensoussan, D.; ;
Affiliations: CNRS, UMR 7561 and FR CNRS-UHP-CHU 3209, Faculté de Médecine, Vandoeuvre-les-Nancy, France | CHU de Nancy, Unité de Thérapie Cellulaire et Tissulaire, Hôpitaux de Brabois, Vandoeuvre-les-Nancy, France | Nancy Université, Université Henri Poincaré, Nancy, France | Department of Biotherapy, Medical College and Zhongnan University Hospital, Wuhan University, Wuhan, China | Biomedical Research Center, Hôpital Universitaire Calmette, Kunming, China | Beijing Institute of Cardiovascular Diseases, Anzen Univertsity Hospital, Beijing, China
Note: [] Address for correspondence: J.-F. Stoltz, CNRS, UMR 7561 and FR CNRS-UHP-CHU 3209, Faculté de Médecine, 54500 Vandoeuvre-les-Nancy, France and UTCT, CHU de Nancy, 54500 Vandoeuvre-les-Nancy, France. E-mail: [email protected].
Abstract: Human tissues don't regenerate spontaneously, explaining why regenerative medicine and cell therapy represent a promising alternative treatment (autologous cells or stem cells of different origins). The principle is simple: cells are collected, expanded and introduced with or without modification into injured tissues or organs. Among middle-term therapeutic applications, cartilage defects, bone repair, cardiac insufficiency, burns, liver or bladder, neurodegenerative disorders could be considered.
Keywords: Stem cells, cell therapy, tissue engineering, biotissue, scaffold, mechanotransduction
DOI: 10.3233/BME-2012-0684
Journal: Bio-Medical Materials and Engineering, vol. 22, no. 1-3, pp. 3-16, 2012
